Clinical Trials Browser

Terminated × Neoplasms × cabozantinib × Clear all

NCT01428219 2017-12-12

Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone

Phase 2 Terminated

25 enrolled 12 charts

Neoplasm Metastasis, Neoplasms